EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma

Berta Mosleh iD, Stefan Schwarz, Anna Cho, Katharina Sinn, Ariane Steindl, Sabine Zöchbauer-Müller, Wolfgang J Köstler, Karin Dieckmann, Martin Heilmann, Joachim Widder iD, Daniela Gompelmann, Clemens Aigner und 2 weitere

Thoracic Cancer · 2025

DOI: 10.1111/1759-7714.70024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Berta Mosleh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Mesothelioma, Malignant, Neoadjuvant Therapy, Pleural Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Few malignancies provoke as many controversies about treatment as pleural mesothelioma. There is limited experience with novel radiotherapy techniques worldwide in adjuvant and particularly in neoadjuvant settings within multimodality treatment. The objective of the current study was to investigate the long‐term outcome of neoadjuvant and adjuvant pleural intensity‐modulated radiotherapy (IMRT) combined with macroscopic complete resection with or without chemotherapy.

Methods

We retrospectively analyzed a consecutive cohort of 59 patients who were diagnosed with pleural mesothelioma and underwent multimodality treatment including macroscopic complete resection and neoadjuvant or adjuvant IMRT between 2005 and 2019 at the Department of Thoracic Surgery, Medical University of Vienna, Austria.

Results

In total, 59 patients (median age 59 years; IQR 54–66, male, n = 48; 81%) were included. Forty‐seven patients underwent trimodality treatment consisting of induction chemotherapy, extrapleural pneumonectomy, and adjuvant IMRT. Novel neoadjuvant IMRT with ( n = 9) or without ( n = 3) chemotherapy followed by extrapleural pneumonectomy was performed in 12 patients. Median overall survival (OS) of all patients was 23.2 months (95% CI; 18.1–28.2) and 3‐ and 5‐year survival rates were 33% and 28%, respectively. Survival was comparable between therapies including neoadjuvant versus adjuvant IMRT (median OS 17.5 vs. 24.0 months, p = 0.39).

Conclusions

Neoadjuvant pleural IMRT has been investigated as a novel treatment option for highly selected cases in pleural mesothelioma. Neoadjuvant IMRT was effective and safe in patients treated in a high‐volume institution but showed no relevant survival benefit compared to adjuvant IMRT within multimodality treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedMesothelioma, MalignantNeoadjuvant TherapyPleural NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesCombined Modality TherapyRadiotherapy, Adjuvant

Stichwörter der Autor:innen

intensity‐modulated radiotherapy (IMRT)macroscopic complete resectionmultimodality treatmentpleural mesothelioma

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Division of Oncology, Department of Internal Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Division of Pulmonology, Department of Internal Medicine II, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Berta Mosleh, Joachim Widder

Zitieren

APA

Mosleh, B., Schwarz, S., Cho, A., Sinn, K., Steindl, A., Zöchbauer-Müller, S., Köstler, W. J., Dieckmann, K., Heilmann, M., Widder, J., Gompelmann, D., Aigner, C., Klikovits, T., & Hoda, M. A. (2025). Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70024

Vancouver

Mosleh B, Schwarz S, Cho A, Sinn K, Steindl A, Zöchbauer-Müller S, et al. Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70024

BibTeX
@article{Mosleh2025,
  author = {Mosleh, Berta and Schwarz, Stefan and Cho, Anna and Sinn, Katharina and Steindl, Ariane and Zöchbauer-Müller, Sabine and Köstler, Wolfgang J and Dieckmann, Karin and Heilmann, Martin and Widder, Joachim and Gompelmann, Daniela and Aigner, Clemens and Klikovits, Thomas and Hoda, Mir Alireza},
  title = {Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma},
  journal = {Thoracic Cancer},
  year = {2025},
  doi = {10.1111/1759-7714.70024}
}
Kostenlos starten →